Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Millennium Hotel London Mayfair

Dec 08, 2017 9:00 AM - Dec 08, 2017 5:15 PM

44 Grosvenor Square Mayfair, London, W1K 2HP, United Kingdom

DIA Brexit Summit | Ensuring Continuity for Patients and Business

Session 3: Regulatory Planning – Preparing for Day 1

Session Chair(s)

Zamshed  Harun

Zamshed Harun

CEO

Makaris Strategies, Switzerland

This session will review issues related to licensing, for Day 1 and looking forward. This will summarise what we know, what we still don’t know and what we have to do to be prepared.

Speaker(s)

Chris  Walker, MSc

Industry: Day One Contingency Plans and Practical Considerations

Chris Walker, MSc

Amgen, United Kingdom

VP, Head of Regulatory Affairs (EU,LATAM,MiddleEast,Africa,CAN)

Noël  Wathion, RPh

EMA Relocation and Business Continuity Planning: Insights in the Operations and Relocation Preparedness Task Force

Noël Wathion, RPh

European Medicines Agency, Netherlands

Deputy Executive Director

Peter  Bachmann

Decentralised Arrangements & How Other National Regulators Are Responding to the Brexit Challenge

Peter Bachmann

Federal Institute for Drugs and Medical Devices (BfArM), Germany

Deputy-Head, European Union and International Affairs

Rita  Purcell, LLM

Responding to the Brexit Challenge – Ireland

Rita Purcell, LLM

Health Products Regulatory Authority (HPRA), Ireland

Deputy Chief Executive

Keith  McDonald, MSc

MHRA Relocation and Preparation for Post-Brexit Regulatory Framework

Keith McDonald, MSc

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Deputy Director, Licensing Division

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.